Chlortetracycline

Chlortetracycline antibiotic medicaments in measured doses

MEFCC CLEARANCE

HSN 3004 20 41 (Chlortetracycline) is subject to drug registration and import licensing requirements for pharmaceutical medicaments containing antibiotics, with mandatory documents verified at the bill-of-entry stage under the oversight of the Ministry of Environment, Forest and Climate Change (MEFCC) and the Directorate General of Foreign Trade (DGFT). The tariff line carries an ITC (HS) policy overlay, and customs clearance requires upload of five specified e-Sanchit documents — including a Registration Certificate (Drugs) and an Import Licence for Drugs — before out-of-charge is granted.

What this is

HSN code

3004 20 41

Chapter

30 · Pharmaceutical products

Primary regulator

MEFCC · Ministry of Environment, Forest and Climate Change (legacy code) · ITC (HS) import policy, Chapter 30

Customs documentation

Registration certificate from DGFT/CDSCO
Import licence for drugs from authority
Batch release certificate from manufacturer

Applicable Partner Government Agencies

MEFCCMEFCC·Ministry of Environment, Forest and Climate Change

Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.

Compliance steps

1
Ensure the drug registration certificate (document code 101dc1) and the Import Licence for Drugs (document code 9111dc) are current and valid before shipment. Both documents must be uploaded in e-Sanchit at the bill of entry; customs out-of-charge will not be granted until both are verified.
CCR e-Sanchit mandatory documents: 101dc1, 9111dc
2
Upload all five mandatory documents in e-Sanchit before the bill of entry is filed: Certificate of Analysis – Drug (0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate (Drugs) (101dc1), and Import Licence for Drugs (9111dc). The proper officer is required to verify all five before granting out-of-charge on PGA-facilitated bills.
CCR e-Sanchit mandatory document codes: 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
3
Note the absolute prohibition on import of oxytocin under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022; import of oxytocin reference standards is permitted solely for test and analysis purposes on submission of a test licence issued by DGCI/CDSCO. Confirm the chlortetracycline consignment does not contain any scheduled prohibited substance.
S.O. 2357(E) · DGFT Notification 09/2015-2020 dated 23-05-2022

A word of counsel

The most frequent error on this tariff line is treating the drug registration certificate and the import licence as interchangeable or assuming one suffices for the other — they are separate, independently mandatory documents with distinct issuing authorities, and the absence of either triggers consignment detention at the port of entry. Importers should also confirm that the batch release certificate (0030dc) is consignment-specific and issued by the manufacturing facility, not a generic product certificate, as a generic certificate will not satisfy the proper officer's pre-OOC verification requirement.

Need a regulatory steer on this product?

Speak to a regulatory counsel about your specific HSN, IS, and supplier situation.

Speak to an Expert

Frequently asked

Does HSN 3004 20 41 require BIS certification?

No, no BIS Quality Control Order covers antibiotic medicaments under this tariff line. Import is governed by drug registration and import licensing requirements enforced through MEFCC and DGFT policy controls, with five mandatory e-Sanchit documents required at the bill of entry.

What are the five mandatory e-Sanchit document codes for this tariff line?

The five documents are: Certificate of Analysis – Drug (0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate (Drugs) (101dc1), and Import Licence for Drugs (9111dc); all must be uploaded before customs out-of-charge is granted.

Does the prohibition on oxytocin imports affect chlortetracycline consignments?

Not directly, but the prohibition under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022 applies to the broader Chapter 30 import framework; importers must confirm no prohibited substance is co-shipped, and oxytocin reference standards remain permissible only on production of a DGCI/CDSCO test licence.

Last verified against gazette notifications: 2026-05-16. Source: MEFCC / DGFT / Indian Customs CUSDATA.